ON 01910
Showing 1 - 25 of 55
Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Melanoma Trial in
Not yet recruiting
- Clinical Stage III Cutaneous Melanoma AJCC v8
- +4 more
- Rigosertib
- +4 more
-
Nashville, TennesseeVanderbilt University/Ingram Cancer Center
Feb 28, 2023
Recessive Dystrophic Epidermolysis Bullosa Trial in Philadelphia (Rigosertib Sodium, Quality-of-Life Assessment)
Recruiting
- Recessive Dystrophic Epidermolysis Bullosa
- Rigosertib Sodium
- Quality-of-Life Assessment
-
Philadelphia, PennsylvaniaSidney Kimmel Cancer Center at Thomas Jefferson University
Aug 31, 2021
Myelodysplastic Syndrome (MDS) Trial run by the NHLBI (ON 01910 Na)
Completed
- Myelodysplastic Syndrome (MDS)
- ON 01910 Na
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 14, 2019
Phase II Cont. IV of ON 01910.Na in MDS w/ Trisomy 8/Intermed-1,
Completed
- Myelodysplastic Syndromes
-
Stanford, CaliforniaStanford University School of Medicine
Mar 23, 2020
Leukemia, Myelofibrosis, Anemia Trial in Houston (Rigosertib, Questionnaire)
Terminated
- Leukemia
- +3 more
- Rigosertib
- Questionnaire
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Aug 5, 2020
MDS Trial in France, Germany, United States (Oral rigosertib)
Completed
- Myelodysplastic Syndromes
- Oral rigosertib
-
Stanford, California
- +13 more
Jun 15, 2021
Lymphoma, Mantle-cell, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Hairy Cell Trial run by the NHLBI (ON01910 Na)
Completed
- Lymphoma, Mantle-cell
- +4 more
- ON01910 Na
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Nov 30, 2019
Myelodysplastic Syndrome Trial in New York (rigosertib)
Withdrawn
- Myelodysplastic Syndrome
-
New York, New YorkColumbia University Medical Center
Jun 29, 2020
Myelodysplastic Syndrome, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia Trial in France, United States (oral
Completed
- Myelodysplastic Syndrome
- +2 more
- oral rigosertib
- Azacitidine
-
Gilbert, Arizona
- +12 more
Jun 15, 2021
MDS, MDS, RAEB Trial in Worldwide (ON 01910.Na)
Completed
- Myelodysplastic Syndromes
- +3 more
- ON 01910.Na
-
Scottsdale, Arizona
- +86 more
Jun 29, 2020
Right Portal Vein Diameter
Completed
- Intrauterine Growth Retardation (IUGR)
- Ultrasound
-
Poitiers, FranceC.H.U. de Poitiers
Oct 10, 2022
Epidermolysis Bullosa Dystrophica, Squamous Cell Carcinoma Trial in Salzburg (Rigosertib Oral Capsules / Rigosertib Intravenous)
Recruiting
- Epidermolysis Bullosa Dystrophica
- Squamous Cell Carcinoma
- Rigosertib Oral Capsules / Rigosertib Intravenous
-
Salzburg, AustriaEB House Austria/Dept. of Dermatology University Hospital
Nov 3, 2022
Chronic Pelvic Pain, Myofascial Trigger Point Pain Trial in Lahore (TENS, Myofascial trigger point release)
Recruiting
- Chronic Pelvic Pain
- Myofascial Trigger Point Pain
- TENS
- Myofascial trigger point release
-
Lahore, Punjab, PakistanJinnah Hospital Lahore
May 9, 2023
Myelodysplastic Syndrome, MDS, Refractory Anemia With Excess Blasts Trial in Worldwide (rigosertib, Any approved or
Terminated
- Myelodysplastic Syndrome
- +3 more
- rigosertib
- +2 more
-
La Jolla, California
- +157 more
Sep 22, 2022
NSCLC, Adenocarcinoma, Stage IV Trial in New York (Rigosertib, Nivolumab)
Recruiting
- Non-small Cell Lung Cancer
- +2 more
-
New York, New YorkIcahn School of Medicine at Mount Sinai
Feb 8, 2022
MDS, Refractory Anemia With Excess Blasts, Chronic Myelomonocytic Leukemia Trial in Worldwide (rigosertib sodium)
Completed
- Myelodysplastic Syndromes
- +3 more
- rigosertib sodium
-
Stanford, California
- +34 more
Jun 29, 2020
Chronic Ulcer of Leg or Foot, Diabetic Foot Ulcer, Arterial Ulcer Trial in Montpellier (CACIPLIQ20®)
Recruiting
- Chronic Ulcer of Leg or Foot
- +3 more
- CACIPLIQ20®
-
Montpellier, FranceRéseau Cicat-Occitanie
Feb 24, 2022
Methylation, mIcrobiome, NUtritional sTatus, and dEvelopment of
Not yet recruiting
- Stunting
- +4 more
- (no location specified)
Mar 9, 2023
Tension, Headache Trial in Lafayette (HLNatural Tension)
Completed
- Tension
- Headache
- HLNatural Tension
-
Lafayette, CaliforniaHawthorne Effect, Inc.
Nov 5, 2021
Vaginal Atrophy Trial in Dallas (IntraGen RF, DiVA)
Completed
- Vaginal Atrophy
- IntraGen RF
- +2 more
-
Dallas, TexasUniversity of Texas Southwestern Medical Center
Dec 9, 2022
Acute Myelocytic Leukemia, Acute Lymphocytic Leukemia, Chronic Myelocytic Leukemia Trial in New York (ON 01910.Na)
Completed
- Acute Myelocytic Leukemia
- +4 more
- ON 01910.Na
-
New York, New YorkMount Sinai Medical Center
Jan 9, 2018
Helicobacter Pylori Infection Trial in Kaohsiung (rabeprazole+3 antibiotics, rabeprazole+bismuth+2 antibiotics,
Unknown status
- Helicobacter Pylori Infection
- rabeprazole+3 antibiotics
- +2 more
-
Kaohsiung, TaiwanKaohsiung Veterans General Hospital
Mar 18, 2021
Hypertension, Genetics Hypertension Trial in Boston (Eplerenone vs Amlodipine)
Recruiting
- Hypertension
- Genetics Hypertension
- Eplerenone vs Amlodipine
-
Boston, MassachusettsBrigham and Women's Hospital
Nov 11, 2021
Childhood Hepatocellular Carcinoma, Childhood Malignant Liver Tumor, Fibrolamellar Carcinoma Trial in Worldwide (drug, other,
Recruiting
- Childhood Hepatocellular Carcinoma
- +4 more
- Carboplatin
- +12 more
-
Birmingham, Alabama
- +201 more
Jan 30, 2023
Ovarian Cancer Trial in Indianapolis (ON 01910.Na)
Completed
- Ovarian Cancer
- ON 01910.Na
-
Indianapolis, IndianaSt. Vincent Gynecologic Oncology
Jun 22, 2017